ArticleNeuro-oncology2025

MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma.

Magretta Adiamah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.